.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Argus Health
Federal Trade Commission
US Department of Justice
Daiichi Sankyo
QuintilesIMS
Medtronic
Express Scripts
Fish and Richardson
Farmers Insurance

Generated: January 19, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: daclatasvir dihydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Bristol-myers SquibbDAKLINZAdaclatasvir dihydrochlorideTABLET;ORAL206843NDAE.R. Squibb & Sons, L.L.C.0003-0011-0128 TABLET in 1 BOTTLE (0003-0011-01)
Bristol-myers SquibbDAKLINZAdaclatasvir dihydrochlorideTABLET;ORAL206843NDAE.R. Squibb & Sons, L.L.C.0003-0213-0128 TABLET in 1 BOTTLE (0003-0213-01)
Bristol-myers SquibbDAKLINZAdaclatasvir dihydrochlorideTABLET;ORAL206843NDAE.R. Squibb & Sons, L.L.C.0003-0215-0128 TABLET in 1 BOTTLE (0003-0215-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Dow
US Department of Justice
Harvard Business School
Baxter
McKesson
US Army
QuintilesIMS
Mallinckrodt
Cipla

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot